Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases

Digestive Diseases and Sciences

Volumn 46, Issue 5, 2001, Pages 993-996

  Brunner, G ^a   Athmann, C ^a   Boldt, J H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Edema; Females; Proton pump inhibitors

Indexed keywords

ANTIULCER AGENT; DIURETIC AGENT; FUROSEMIDE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPETITIVE INHIBITION; DIGESTIVE SYSTEM ULCER; DRUG INDUCED DISEASE; DRUG MEGADOSE; DUODENUM ULCER; EDEMA; FEMALE; FLUID BALANCE; HEART FAILURE; HORMONAL REGULATION; HUMAN; LEG EDEMA; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH ULCER; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-ULCER AGENTS; BENZIMIDAZOLES; EDEMA; FEMALE; HUMANS; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; PROTON PUMPS; SULFOXIDES;

EID: 0035039452     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010745624971     Document Type: Article

References (21)

1. Value of omeprazole in the management of erosive oesophagitis refractory to high dose cimetidine
2. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer
3. European Pantoprazole Study Group: A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer: A multicenter trail
4. Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine
5. Lansoprazole versus ranitidine in the treatment of duodenal ulcers: Results of a multicentre, controlled, randomized, double-blind study in parallel groups
6. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment
7. Appropriate acid suppression for the management of gastroesophageal reflux disease
8. Meta-analysis of the efficacy of antibiotic therapy in eradicating H. pylori
9. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine
10. 2-receptor antagonists: Intragastric acidity in patients with duodenal ulcer
11. Do continuous infusions of ome prazole retain their effect with prolonged dosing?
12. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: An open randomized controlled trial
13. Beneficial effects of i.v. omeprazole in patients with peptic ulcer bleeding
14. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine
15. Omeprazole improves outcome in peptic ulcer bleeding
16. An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment
17. Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment
18. Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell, growth, and gastritis
19. Omeprazole for peptic ulcer disease in pregnancy
20. Drugs for pH control in upper gastrointestinal bleeding
21. + ATPase inhibitor (BY 1023/SK & F 96 022) and its sulphone metabolite in serum or plasma by direct injection and fully automated pre-column sample clean-up